| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
28,967,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
3,400 |
Avg
Vol: |
1,577 |
| 52
Week Range: |
$0.4197 - $0.4197 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Business Services |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Calmare Therapeutics and its majority-owned subsidiary, Vector Vision, Inc., is a medical device company engaged in developing and commercializing products and technologies for chronic neuropathic pain and wound care affliction patients. Co.'s primary medical device, the Calmare® Pain Therapy Device (the Calmare Device), is a non-invasive and non-addictive modality that can treat chronic, neuropathic pain. Co. has rights to manufacture and sell the Calmare Device worldwide using the Calmare Pain Mitigation Therapy™.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Brennan Peter F |
Director |
– • – |
2018-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,594,117 |
13,850,181 |
|
- |
|
| Mir Conrad F |
President & CEO |
• • – |
2018-02-12 |
4 |
OE |
$0.08 |
$80,000 |
D/D |
1,000,000 |
1,440,751 |
|
- |
|
| Richtarich Thomas Philip |
Chief Financial Officer |
• – – |
2018-02-12 |
4 |
A |
$0.09 |
$30,000 |
D/D |
333,333 |
333,333 |
|
- |
|
| Howard Rustin R |
Director |
– • – |
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
63,255 |
|
- |
|
| Yarbro Stan |
Director |
– • – |
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
138,242 |
|
- |
|
| Moussa Robert G |
Director |
– • – |
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
7,500 |
|
- |
|
| Brennan Peter F |
Director |
– • • |
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
1,368,615 |
|
- |
|
7 Records found
|
1
|
Page 1 of 1 |
|
|
